News & Media
February 18, 2023
Suspension Cell Culture in Cell and Gene Therapy
The Growing Demand for Suspension Cell Culture Platforms The biopharmaceutical sector is growing and demand for viral vectors as tools...
February 18, 2023
Genetic Engineering
Delivering Genetic Editing Therapies to Market In the past 10 years, our understanding of molecular biology and genetic engineering has...
November 28, 2022
Trends in AAV development and manufacturing for gene therapies
Following pre-clinical and clinical success, adeno-associated viral vectors (AAVs), have become a leading tool for gene delivery in the treatment...
February 28, 2022
Andelyn Biosciences Observes Rare Disease Day
Observed every year on the last day in February, Rare Disease Day works to raise awareness for rare diseases and...
February 11, 2022
Andelyn’s Women in Science
Every day here at Andelyn Biosciences is Women in Science Day! We are proud that 50% of our scientists on...
February 8, 2022
Optimizing Yields, Tech Transfer, and the Supply Chain for Viral Vector Manufacturing
Gene therapies offer an unprecedented ability to treat — and even cure — genetic diseases, and their potential spanning diverse...
November 11, 2021
Leveraging Partnerships and a Unique History to Address Supply Chain and Capacity Challenges in Gene Therapy Manufacturing
Andelyn Biosciences has established a unique network of industry experts across the entire development and commercialization spectrum. In addition to...
October 22, 2021
Coping with a Talent Shortage and Talent War in Cell and Gene Therapy
Andelyn Biosciences is building the best cell and gene therapy team in spite of a talent shortage and competitive talent...
September 23, 2021
Navigating Analytical Requirements for GMP Viral Vectors
The analytical requirements for viral vectors used to deliver gene therapies are complex and constantly evolving. The keys to success,...
September 16, 2021
Building a Bridge of Equivalence to Facilitate and Implement Rapid Process Changes in Gene Therapy Manufacturing
The number of gene therapy candidates in development is growing rapidly, with many advancing toward late-stage trials. The majority of...